MetLife Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.79M Sell
106,725
-14,100
-12% -$236K 0.01% 1045
2025
Q1
$1.86M Sell
120,825
-12,600
-9% -$194K 0.01% 1071
2024
Q4
$2.94M Buy
133,425
+38,400
+40% +$846K 0.02% 847
2024
Q3
$1.71M Sell
95,025
-10,100
-10% -$182K 0.01% 1101
2024
Q2
$1.71M Buy
105,125
+41,872
+66% +$680K 0.01% 1056
2024
Q1
$893K Hold
63,253
0.01% 1360
2023
Q4
$660K Hold
63,253
﹤0.01% 1524
2023
Q3
$645K Hold
63,253
0.01% 1478
2023
Q2
$476K Hold
63,253
﹤0.01% 1719
2023
Q1
$560K Sell
63,253
-12,500
-17% -$111K ﹤0.01% 1578
2022
Q4
$691K Hold
75,753
0.01% 1432
2022
Q3
$611K Hold
75,753
0.01% 1490
2022
Q2
$570K Hold
75,753
﹤0.01% 1567
2022
Q1
$711K Hold
75,753
﹤0.01% 1551
2021
Q4
$607K Hold
75,753
0.01% 1407
2021
Q3
$738K Hold
75,753
0.01% 1286
2021
Q2
$750K Hold
75,753
0.01% 1336
2021
Q1
$874K Sell
75,753
-13,400
-15% -$155K 0.01% 1221
2020
Q4
$860K Hold
89,153
0.01% 1203
2020
Q3
$803K Buy
89,153
+11,200
+14% +$101K 0.01% 1139
2020
Q2
$961K Hold
77,953
0.01% 1055
2020
Q1
$700K Hold
77,953
0.01% 1053
2019
Q4
$764K Hold
77,953
0.01% 1232
2019
Q3
$536K Hold
77,953
0.01% 1384
2019
Q2
$720K Buy
77,953
+7,600
+11% +$70.1K 0.01% 1276
2019
Q1
$1.1M Hold
70,353
0.01% 1037
2018
Q4
$1.08M Hold
70,353
0.01% 986
2018
Q3
$1.52M Hold
70,353
0.02% 967
2018
Q2
$1.71M Buy
70,353
+7,600
+12% +$185K 0.02% 840
2018
Q1
$1.07M Sell
62,753
-7,700
-11% -$132K 0.01% 976
2017
Q4
$1.34M Buy
+70,453
New +$1.34M 0.02% 917